BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qi C, Xiaofeng C, Dongen L, Liang Y, Liping X, Yue H, Jianshuai J. Long non-coding RNA MACC1-AS1 promoted pancreatic carcinoma progression through activation of PAX8/NOTCH1 signaling pathway. J Exp Clin Cancer Res. 2019;38:344. [PMID: 31391063 DOI: 10.1186/s13046-019-1332-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Rong Z, Wang Z, Wang X, Qin C, Geng W. Molecular interplay between linc01134 and YY1 dictates hepatocellular carcinoma progression. J Exp Clin Cancer Res 2020;39:61. [PMID: 32272940 DOI: 10.1186/s13046-020-01551-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
2 Farooqi AA, Nayyab S, Martinelli C, Berardi R, Katifelis H, Gazouli M, Cho WC. Regulation of Hippo, TGFβ/SMAD, Wnt/β-Catenin, JAK/STAT, and NOTCH by Long Non-Coding RNAs in Pancreatic Cancer. Front Oncol 2021;11:657965. [PMID: 34178644 DOI: 10.3389/fonc.2021.657965] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Yan G, Zhao H, Hong X. LncRNA MACC1-AS1 attenuates microvascular endothelial cell injury and promotes angiogenesis under hypoxic conditions via modulating miR-6867-5p/TWIST1 in human brain microvascular endothelial cells. Ann Transl Med 2020;8:876. [PMID: 32793720 DOI: 10.21037/atm-20-4915] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
4 Chen S, Luo X, Wu W, Li Y, Yu H, Wang Y, Yan J. The long non-coding RNA MACC1-AS1 promotes nasopharyngeal carcinoma cell stemness via suppressing miR-145-mediated inhibition on SMAD2/MACC1-AS1 axis. Biomed Pharmacother 2020;125:109986. [PMID: 32058221 DOI: 10.1016/j.biopha.2020.109986] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
5 Tornesello ML, Faraonio R, Buonaguro L, Annunziata C, Starita N, Cerasuolo A, Pezzuto F, Tornesello AL, Buonaguro FM. The Role of microRNAs, Long Non-coding RNAs, and Circular RNAs in Cervical Cancer. Front Oncol 2020;10:150. [PMID: 32154165 DOI: 10.3389/fonc.2020.00150] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 24.5] [Reference Citation Analysis]
6 Xu J, Xu W, Yang X, Liu Z, Sun Q. LncRNA HCG11/miR-579-3p/MDM2 axis modulates malignant biological properties in pancreatic carcinoma via Notch/Hes1 signaling pathway. Aging (Albany NY) 2021;13:16471-84. [PMID: 34230221 DOI: 10.18632/aging.203167] [Reference Citation Analysis]
7 Xu T, Lei T, Li SQ, Mai EH, Ding FH, Niu B. DNAH17-AS1 promotes pancreatic carcinoma by increasing PPME1 expression via inhibition of miR-432-5p. World J Gastroenterol 2020; 26(15): 1745-1757 [PMID: 32351291 DOI: 10.3748/wjg.v26.i15.1745] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
8 Seyed Hosseini E, Nikkhah A, Sotudeh A, Alizadeh Zarei M, Izadpanah F, Nikzad H, Haddad Kashani H. The impact of LncRNA dysregulation on clinicopathology and survival of pancreatic cancer: a systematic review and meta-analysis (PRISMA compliant). Cancer Cell Int 2021;21:447. [PMID: 34425840 DOI: 10.1186/s12935-021-02125-1] [Reference Citation Analysis]
9 Xue F, Song X, Zhang S, Niu M, Cui Y, Wang Y, Zhao T. Long non-coding RNA TMPO-AS1 serves as a tumor promoter in pancreatic carcinoma by regulating miR-383-5p/SOX11. Oncol Lett 2021;21:255. [PMID: 33664819 DOI: 10.3892/ol.2021.12517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Wang X, Yu X, Wei W, Liu Y. Long noncoding RNA MACC1-AS1 promotes the stemness of nonsmall cell lung cancer cells through promoting UPF1-mediated destabilization of LATS1/2. Environ Toxicol 2020;35:998-1006. [PMID: 32401390 DOI: 10.1002/tox.22936] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ghafouri-Fard S, Fathi M, Zhai T, Taheri M, Dong P. LncRNAs: Novel Biomarkers for Pancreatic Cancer. Biomolecules 2021;11:1665. [PMID: 34827663 DOI: 10.3390/biom11111665] [Reference Citation Analysis]
12 Lamsisi M, Wakrim L, Bouziyane A, Benhessou M, Oudghiri M, Laraqui A, Elkarroumi M, Ennachit M, El Mzibri M, Ennaji MM. The Biological Significance of Long noncoding RNAs Dysregulation and their Mechanism of Regulating Signaling Pathways in Cervical Cancer. Int J Mol Cell Med 2021;10:75-101. [PMID: 34703793 DOI: 10.22088/IJMCM.BUMS.10.2.75] [Reference Citation Analysis]
13 Gao L, Li Q. Identification of Novel Pyroptosis-Related lncRNAs Associated with the Prognosis of Breast Cancer Through Interactive Analysis. Cancer Manag Res 2021;13:7175-86. [PMID: 34552353 DOI: 10.2147/CMAR.S325710] [Reference Citation Analysis]
14 Malla RR, Padmaraju V, Marni R, Kamal MA. Natural products: Potential targets of TME related long non-coding RNAs in lung cancer. Phytomedicine 2021;93:153782. [PMID: 34627097 DOI: 10.1016/j.phymed.2021.153782] [Reference Citation Analysis]
15 Zhao L, Liu T, Zhang X, Zuo D, Liu C. lncRNA RHPN1-AS1 Promotes Ovarian Cancer Growth and Invasiveness Through Inhibiting miR-1299. Onco Targets Ther 2020;13:5337-44. [PMID: 32606751 DOI: 10.2147/OTT.S248050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Li J, Lei C, Chen B, Zhu Q. LncRNA FGD5-AS1 Facilitates the Radioresistance of Breast Cancer Cells by Enhancing MACC1 Expression Through Competitively Sponging miR-497-5p. Front Oncol 2021;11:671853. [PMID: 34221989 DOI: 10.3389/fonc.2021.671853] [Reference Citation Analysis]
17 Li Z, Sun X. Non-Coding RNAs Operate in the Crosstalk Between Cancer Metabolic Reprogramming and Metastasis. Front Oncol 2020;10:810. [PMID: 32547948 DOI: 10.3389/fonc.2020.00810] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
18 Wang L. ELF1-activated FOXD3-AS1 promotes the migration, invasion and EMT of osteosarcoma cells via sponging miR-296-5p to upregulate ZCCHC3. J Bone Oncol 2021;26:100335. [PMID: 33204608 DOI: 10.1016/j.jbo.2020.100335] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Guo Y, Zhong J, Wu F, Zhan Z. Long noncoding RNA MACC1-AS1 promotes the stemness of hepatocellular carcinoma cells by antagonizing miR-145. J Int Med Res 2020;48:300060520920411. [PMID: 32339066 DOI: 10.1177/0300060520920411] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Wu B, Yang C, Fang Y, Ding W, Zhang Y. Long noncoding RNA DUXAP10 promotes the stemness of glioma cells by recruiting HuR to enhance Sox12 mRNA stability. Environ Toxicol 2021;36:840-9. [PMID: 33340249 DOI: 10.1002/tox.23087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Tong H, Liu X, Li T, Qiu W, Peng C, Shen B, Zhu Z. MACC1-AS1 promotes hepatocellular carcinoma cell invasion and proliferation by regulating PAX8. Aging (Albany NY) 2020;12:70-9. [PMID: 31915309 DOI: 10.18632/aging.102585] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Jafarzadeh A, Paknahad MH, Nemati M, Jafarzadeh S, Mahjoubin-Tehran M, Rajabi A, Shojaie L, Mirzaei H. Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target. Biomed Pharmacother 2021;146:112600. [PMID: 34968919 DOI: 10.1016/j.biopha.2021.112600] [Reference Citation Analysis]
23 Wang Y, Zhou L, Lu J, Jiang B, Liu C, Guo J, Xiao GG. Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancreatic cancer. Cancer Cell Int. 2020;20:457. [PMID: 32973402 DOI: 10.1186/s12935-020-01550-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
24 Wen J, Xie Y, Zhang Y, Li J, Li J, Zhang Y, Lu X, Zhang Y, Liu Y, Liu T, Li L. MACC1 Contributes to the Development of Osteosarcoma Through Regulation of the HGF/c-Met Pathway and Microtubule Stability. Front Cell Dev Biol 2020;8:825. [PMID: 33425885 DOI: 10.3389/fcell.2020.00825] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Xue W, Shen Z, Li L, Zheng Y, Yan D, Kan Q, Zhao J. Long non-coding RNAs MACC1-AS1 and FOXD2-AS1 mediate NSD2-induced cisplatin resistance in esophageal squamous cell carcinoma. Mol Ther Nucleic Acids 2021;23:592-602. [PMID: 33552680 DOI: 10.1016/j.omtn.2020.12.007] [Reference Citation Analysis]
26 Yan L, Zhang Z, Yin X, Li Y. lncRNA NEAT1 Facilitates Cell Proliferation, Invasion and Migration by Regulating CBX7 and RTCB in Breast Cancer. Onco Targets Ther 2020;13:2449-58. [PMID: 32273717 DOI: 10.2147/OTT.S240769] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
27 Zheng D, Che D, Lin F, Wang X, Lu L, Chen J, Xu X. LncRNA MACC1-AS1/MACC1 enhances the progression of glioma via regulating metabolic plasticity. Cell Cycle 2020;19:2286-97. [PMID: 32816608 DOI: 10.1080/15384101.2020.1795595] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]